CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | KAPLAN GILLA Director | Option exercise | −53,172 | $2.25 | $120K | 81,403 |
| 2026-03-26 | KAPLAN GILLA Director | Returned to the company | −53,172 | $37.75 | $2.0M | 28,231 |
| 2026-03-26 | KAPLAN GILLA Director | Option exercise · Stock Option (Right to Buy) | −53,172 | 0 | ||
| 2026-03-25 | KAPLAN GILLA Director | Option exercise | +14,295 | $2.25 | $32K | 42,526 |
| 2026-03-25 | KAPLAN GILLA Director | Sale | −14,295 | $36.97 | $529K | 28,231 |
| 2026-03-25 | KAPLAN GILLA Director | Option exercise · Stock Option (Right to Buy) | −14,295 | 53,172 | ||
| 2025-06-18 | KAPLAN GILLA Director | Sale | −9,568 | $9.78 | $94K | 28,231 |
| 2025-06-17 | KAPLAN GILLA Director | Sale | −10 | $10.35 | $104 | 37,799 |
| 2025-06-16 | KAPLAN GILLA Director | Sale | −6,814 | $10.38 | $71K | 37,809 |
| 2025-06-13 | KAPLAN GILLA Director | Sale | −15,000 | $10.31 | $155K | 44,623 |
| 2025-06-12 | KAPLAN GILLA Director | Sale | −30,000 | $10.31 | $309K | 59,623 |
| 2025-05-29 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2024-06-13 | KAPLAN GILLA Director | Option exercise | +61,392 | $0.61 | $37K | 89,623 |
| 2024-06-13 | KAPLAN GILLA Director | Option exercise · Stock Option (Right to Buy) | −61,392 | 0 | ||
| 2024-05-29 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2023-05-31 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 |
Page 1 of 1 · 17 trades